Skip to main content
TipRanks
Go Ultimate75% OFF

Careteq Ltd. (CTQ) AI Stock Analysis

1 Followers
AU:CTQ

Careteq Ltd.

(ASX:CTQ)

Select Model
Rating:44Neutral
Price Target:AUD 0.01â–²(0.00% Upside)
Action:reiterated
Date:11/07/26

The overall score of 44 is very low, driven primarily by severe operational and cash flow weaknesses. The company is burning cash rapidly while revenues contract, which is the most significant risk. This is compounded by a bearish technical trend with the stock trading below all major moving averages. While the balance sheet is deleveraged, it does not offset the immediate threats from an unprofitable business model and negative market momentum.

Positive Factors
Revenue GrowthThe sharp 2026 revenue step-up indicates improving commercial traction and broader adoption of Careteq’s healthcare technology solutions. If sustained, stronger scale can support operating leverage, deepen customer relationships, and provide a larger base for future profitability.
Negative Factors
Persistent Net LossesPersistent net losses show that Careteq’s growing revenue has not yet translated into sustainable earnings. Without a durable path to profitability, the company may have less capacity to reinvest, absorb setbacks, or create value from its healthcare technology platform over coming periods.

Careteq Ltd. (CTQ) vs. iShares MSCI Australia ETF (EWA)

0%20%40%60%80%100%AU:CTQ0.00%EWA+8.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 6.60M
Dividend Yield
―
Average Volume (3M)
1.56M
Price to Earnings (P/E)
-7.5
Beta (1Y)
0.04
Revenue Growth
-20.21%
EPS Growth
-66.67%
Country
Australia
Employees
686
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Careteq Ltd. Business Overview & Revenue Model

Company Description

Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company provides healthcare safety and clinical services. Careteq Limited was incorporated in 2016 and is based in Melb...

Careteq Ltd. Financial Statement Overview

Summary

Financial performance is weak. The income statement shows a sharp revenue decline and a return to operating losses, with volatile margins. The balance sheet is a relative strength after significant deleveraging, but the cash flow statement reveals persistent and worsening cash burn, which is a critical risk. The overall financial health is poor due to an unprofitable, cash-consuming core business.

Income Statement

45Neutral

Balance Sheet

72Positive

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue6.08M6.08M7.62M7.23M4.98M4.43M
Gross Profit5.79M5.79M1.50M6.74M-2.44M4.14M
EBITDA13.95K13.95K275.62K-826.62K-2.65M-5.90M
Net Income246.13K-398.12K-72.20K-2.67M-4.33M-5.25M
Balance Sheet
Total Assets3.78M3.78M5.94M6.82M7.57M8.02M
Cash, Cash Equivalents and Short-Term Investments3.19M3.19M1.05M1.25M1.85M4.50M
Total Debt47.56K47.56K2.37M192.98K961.96K0
Total Liabilities549.17K549.17K4.42M3.30M4.02M1.72M
Stockholders Equity3.23M3.23M1.52M1.97M2.14M6.30M
Cash Flow
Free Cash Flow-1.56M-1.56M-804.93K-2.59M-3.42M-4.54M
Operating Cash Flow-1.50M-1.50M-732.06K-1.30M-2.53M-4.52M
Investing Cash Flow3.92M3.92M119.16K-570.80K-799.63K-256.83K
Financing Cash Flow-278.85K-278.85K400.96K1.27M687.55K8.81M

Careteq Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price0.01

Price Trends

50DMA0.01Negative
100DMA0.01Negative

Market Momentum

MACD-0.00Negative
RSI42.74Neutral
STOCH25.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CTQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 42.74 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CTQ.

Careteq Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

AU:CTQ against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AU:ALCAU:ALC69NeutralAUD 164.00M74.702.53%―26.61%38.21%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
AU:ONEAU:ONE48NeutralAUD 113.29M-6.36-203.69%―-1.53%28.29%
AU:BMTAU:BMT45NeutralAUD 20.08M-1.03-58.13%―2.08%-195.31%
AU:CTQAU:CTQ44NeutralAUD 6.60M-7.5011.00%―-20.21%-66.67%
AU:ICRAU:ICR37UnderperformAUD 12.16M-5.00-416.53%―113.42%29.17%
AU:PCKAU:PCK37UnderperformAUD 14.02M-1.47-1688.04%―11.45%0.69%

* Healthcare Sector Average

Performance Comparison

-50%0%50%AU:CTQAU:ONEAU:BMTAU:ALCAU:ICRAU:PCKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:CTQ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:CTQCareteq Ltd.0.010.000.00%
AU:ONEOneview Healthcare PLC Chess Depository Interests repr 10.14-0.16-55.00%
AU:BMTBeamtree Holdings Ltd0.07-0.14-67.50%
AU:ALCAlcidion Group Limited1.270.2220.95%
AU:ICRInteliCare Holdings Limited0.02-0.01-34.62%
AU:PCKPainChek Ltd0.06-0.31-82.70%

Careteq Ltd. Corporate Events

Careteq Appoints Digital Health Executive to Advisory Board

Nov 6, 2026

Careteq is an Australian clinical healthtech company providing AI-enabled healthcare solutions, including its HMR Referrals marketplace for streamlining Home Medicines Reviews. The company focuses on healthcare technology and digital services designe...

Careteq Advances AI-Enabled HMR Platform as Cash Reserves Support Growth

Oct 30, 2026

Careteq has advanced development of its HMR Referrals platform, adding workflow tools that centralise referral intake, pharmacist allocation, appointment scheduling, report preparation and follow-up in a single environment. For GPs and practices, new...

Careteq Sets 2026 AGM, Emphasises Proxy Voting and Compliance

Oct 26, 2026

Careteq Limited has scheduled its 2026 Annual General Meeting for 27 November in Melbourne, with shareholders eligible to vote based on the share register as at the evening of 25 November. The company is encouraging investors to use proxy voting and...

Careteq Sets Date and Nomination Deadline for 2026 AGM

Oct 1, 2026

Careteq Limited has scheduled its 2026 Annual General Meeting for 10:00am AEDT on 27 November 2026, in line with ASX listing rules and its constitution. The company has also set 5:00pm AEDT on 9 October 2026 as the deadline for written nominations fr...

Careteq Lodges Form 605 Notice on Changes in Substantial Shareholding

Sep 18, 2026

Careteq Ltd. has released a Form 605 notice under Section 671B of the Corporations Act 2001, recording that a holder has ceased to be a substantial shareholder and detailing potential changes in relevant interests and associations in its voting secur...

Careteq Says No Undisclosed News Behind Share Price Surge

Sep 10, 2026

Careteq Limited, an ASX-listed provider of technology-enabled care solutions for vulnerable and elderly individuals, focuses on remote monitoring, emergency alert systems and connected-care platforms for both institutional and private customers. The...

ReNerve Outlines 2026 Governance Framework Aligned with ASX Principles

Aug 27, 2026

ReNerve Limited has reaffirmed its adherence to the ASX Corporate Governance Principles and Recommendations in its 2026 corporate governance statement, detailing the board’s responsibility for strategy, risk management, and shareholder accountability...

Careteq Files Updated Corporate Governance Statement with ASX

Aug 27, 2026

Careteq Limited has lodged its Corporate Governance Statement for the year ended 30 June 2026 with the ASX, confirming it is current as at 27 August 2026 and accessible via the company’s investor centre website. The filing complies with ASX Listing R...

Careteq Resets Balance Sheet and Doubles Down on HMR Referrals Platform

Aug 27, 2026

Careteq has completed a major balance sheet and strategic reset in FY26, divesting its Embedded Health Solutions business, repaying all borrowings, raising $2.2 million in new equity and converting all convertible notes into shares. The company finis...

Careteq books deeper loss as subsidiary sale reshapes balance sheet

Aug 27, 2026

Careteq Limited reported a 21.3% fall in revenues to $6.08 million for the year to June 30, 2026, and a sharply higher after-tax loss of $398,121, with no dividends declared. Despite the weaker operating performance, net tangible assets per share imp...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026